Access-site bleeding and radial artery occlusion in transradial primary percutaneous coronary intervention

Hromádka, Milan; Bernát, Ivo; Seidlerová, Jitka; Jirouš, Štěpán; Dragounová, Eva; Pechman, Vratislav; Tůmová, Pavlína; Rokyta, R

doi:10.1097/mca.0000000000000352

Cited by 8 publications

(4 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…14,15 While some studies have reported lower incidence of hematoma, Hromádka et al and Susanu et al reported hematoma in 6.28% and 6.12% patients after TRA-PCI respectively. 16,17 The variation in incidence of hematoma may be due to diversity in definition to define hematoma in different studies, experience of interventionists and size of sheath used to vascular access. However, the sheath size may or may not be the predictor of hematoma, a recent study compared the outcomes of TRA-PCI with sheath versus without sheath, the authors did not reported any significant in incidence of hematoma in sheath and sheath-less PCI groups.…”

Section: Discussionmentioning

confidence: 99%

Incidence and Risk Factors of Forearm Hematoma After Transradial Percutaneous Coronary Intervention

Saleemi¹,

Mohyuddin

Ahmad

et al. 2020

Pak Heart J

View full text Add to dashboard Cite

Objective: To determine the incidence and risk factors of forearm hematoma after trans-radial percutaneous coronary intervention (TRA-PCI). Methodology: In this observational study we included 450 consecutive patients who were referred to catheterization unit of Ch. Pervaiz Elahi Institute of cardiology between February 2019 and September 2019 were included. Patients planned for TRA were only included in analysis. We recorded demographic details, previous and presenting medical and clinical history, and renal parameters for each patient. Allen’s test was performed in each patient to determine the eligibility TRA. Incidence of forearm hematoma was noted immediately after the procedure. Results: Out of 450 subjects enrolled in this study included, 324 (72%) were men and 126 (28.0%) were women, the mean age of the patients was 54±10 years. Forearm hematoma was diagnosed in only 51 (11.3%) patients. out of 51, 24 (47.0%) had grade I, 17 (33.3%) had grade II and 9 (17.6%) had grade III and 1 (1.96%) patients had grade IV hematoma. On univariate analysis, being women [odds ratio 2.2 (1.2-4.0), p-value=0.01], obesity [odds ratio 2.8 (1.54-5.76), p-value=0.001], and >1 puncture attempt [odds ratio 4.5 (2.36-8.51), p<0.001], were independent risk factors of forearm hematoma. Conclusion: Incidence of hematoma after trans-radial percutaneous coronary intervention is 11.3%. Female gender, obesity and higher number of puncture attempts are independent risk factors of hematoma. Hematoma is mostly grade I-II in nature and can be managed easily only through conservative management.

show abstract

Section: Discussionmentioning

confidence: 99%

Incidence and Risk Factors of Forearm Hematoma After Transradial Percutaneous Coronary Intervention

Saleemi¹,

Mohyuddin

Ahmad

et al. 2020

Pak Heart J

View full text Add to dashboard Cite

show abstract

“…Výskyt lokálních krvácivých komplikací byl v naší studii nízký a všechny hematomy byly klinicky nevýznamné. V jiné studii z našeho pracoviště [13], jež srovnávala výskyt lokálních komplikací u pacientů s akutním koronárním syndromem s elevacemi úseků ST léčených primární PCI, byl ve skupině pacientů bez abciximabu výskyt hematomu II. stupně 5 % a III.…”

Section: Diskuseunclassified

Patent hemostasis and comparison of two compression devices after transradial coronary catheterization and intervention

et al. 2018

Self Cite

View full text Add to dashboard Cite

Cíl: Cílem práce bylo porovnat dva kompresní prostředky po transradiální koronární katetrizaci a intervenci. Metody: Z konsekutivně zařazených 280 pacientů, katetrizovaných a intervenovaných (n = 74) v programu jednodenní hospitalizace, jich mělo 140 komprimováno radiální tepnu po výkonu pomocí kompresního prostředku TR Band (TB) a 140 pomocí prostředku Seal-One (SO). Hodnotili jsme dobu potřebnou k dosažení perfuzní hemostázy, celkovou dobu komprese a lokální komplikace. Výsledky: Perfuzní hemostáza v TB skupině byla dosažena za 17,5 ± 10,3 min, ve skupině SO za 21,4 ± 10,5 min (p = NS). Celková doba komprese radiální tepny dosahovala ve skupině TB 90,7 ± 38,4 min a ve skupině SO 64,0 ± 26,5 min (p < 0,001). Výskyt hematomů ≥ 5 cm byl v obou skupinách stejný (6,4 % vs. 6,4 %, p = NS), výskyt hematomů nad 10 cm byl ve skupině TB 0,7 % a ve skupině SO 1,4 % (p = NS). V obou skupinách nebyly prokázány žádný uzávěr radiální tepny ani další lokální komplikace při propuštění. Závěr: Komprese radiální tepny pomocí prostředků TR Band a Seal-One je spojena s časným dosažením perfuzní hemostázy a krátkou celkovou dobou komprese. Průměrná doba komprese prostředkem Seal-One byla v naší studii kratší. Komprese radiální tepny po výkonu nebyla spojena s výskytem uzávěru radiální tepny při propuštění ani dalšími lokálními komplikacemi kromě nízkého výskytu klinicky nezávažných hematomů.

show abstract

“…Hromádka et al [11], in this issue of Coronary Artery Disease, explore this issue in part, by describing their experience with 334 consecutive STEMI patients who were treated with transradial PCI at their institution. Although nonrandomized, they had three groups of patients of roughly equal size and similar demographics who received clopidogrel, prasugrel, or ticagrelor.…”

mentioning

confidence: 98%

Antiplatelet agents in transradial primary PCI

Seto¹

2016

Coronary Artery Disease

View full text Add to dashboard Cite

Access-site bleeding and radial artery occlusion in transradial primary percutaneous coronary intervention

Cited by 8 publications

References 24 publications

Incidence and Risk Factors of Forearm Hematoma After Transradial Percutaneous Coronary Intervention

Incidence and Risk Factors of Forearm Hematoma After Transradial Percutaneous Coronary Intervention

Patent hemostasis and comparison of two compression devices after transradial coronary catheterization and intervention

Antiplatelet agents in transradial primary PCI

Contact Info

Product

Resources

About